← Back to Screener
Scinai Immunotherapeutics Ltd. American Depositary Shares (SCNI)
Price$0.55
Favorite Metrics
Price vs S&P 500 (26W)-66.43%
Price vs S&P 500 (4W)-27.24%
Market Capitalization$1.92M
P/E Ratio (Annual)0.40x
All Metrics
Book Value / Share (Quarterly)$0.00
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.00
Price vs S&P 500 (YTD)-26.67%
Gross Margin (TTM)-146.99%
Net Profit Margin (TTM)356.67%
EPS (TTM)$0.00
10-Day Avg Trading Volume0.03M
EPS Excl Extra (TTM)$0.00
EPS (Annual)$0.00
ROI (Annual)46.85%
Gross Margin (Annual)-88.15%
Cash / Share (Quarterly)$0.00
P/E Basic Excl Extra (TTM)0.47x
Revenue Growth QoQ (YoY)172.18%
P/E Normalized (Annual)0.40x
ROA (Last FY)35.66%
EBITD / Share (TTM)$0.00
ROE (5Y Avg)-48.50%
Operating Margin (TTM)548.04%
Cash Flow / Share (Annual)$-0.00
P/B Ratio0.24x
P/B Ratio (Quarterly)0.44x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)1.07x
Net Interest Coverage (TTM)4.62x
ROA (TTM)32.69%
EV / EBITDA (TTM)0.15x
EPS Incl Extra (Annual)$0.00
Current Ratio (Annual)1.32x
Quick Ratio (Quarterly)0.60x
3-Month Avg Trading Volume0.05M
52-Week Price Return-72.56%
P/E Incl Extra (TTM)0.47x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$-1.96
P/S Ratio (Annual)2.93x
Asset Turnover (Annual)0.05x
52-Week High$6.18
EPS Excl Extra (Annual)$0.00
CapEx CAGR (5Y)-64.36%
26-Week Price Return-59.54%
Quick Ratio (Annual)1.28x
13-Week Price Return-39.49%
Total Debt / Equity (Annual)0.03x
Current Ratio (Quarterly)0.71x
Enterprise Value$1.229
Asset Turnover (TTM)0.09x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)728.88%
Cash / Share (Annual)$0.00
3-Month Return Std Dev87.93%
Net Income / Employee (TTM)$0
ROE (Last FY)48.07%
Net Interest Coverage (Annual)3.80x
EPS Basic Excl Extra (Annual)$0.00
Receivables Turnover (TTM)8.89x
Total Debt / Equity (Quarterly)0.04x
EPS Incl Extra (TTM)$0.00
ROI (TTM)42.81%
P/S Ratio (TTM)1.68x
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$-0.71
Price vs S&P 500 (52W)-107.19%
P/E Ratio (TTM)0.47x
Year-to-Date Return-22.74%
5-Day Price Return-6.97%
EPS Normalized (Annual)$0.00
ROA (5Y Avg)-13.77%
Net Profit Margin (Annual)728.88%
Month-to-Date Return-3.47%
EBITD / Share (Annual)$0.00
Operating Margin (Annual)930.24%
LT Debt / Equity (Annual)0.03x
ROI (5Y Avg)-24.13%
P/E Excl Extra (TTM)0.47x
LT Debt / Equity (Quarterly)0.04x
EPS Basic Excl Extra (TTM)$0.00
P/B Ratio (Annual)0.29x
Pretax Margin (TTM)356.67%
Book Value / Share (Annual)$0.00
Price vs S&P 500 (13W)-41.87%
Beta2.03x
Revenue / Share (TTM)$0.00
ROE (TTM)44.09%
52-Week Low$0.54
Industry Peers — Biological Products(88)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
SCNIScinai Immunotherapeutics Ltd. American Depositary Shares | 1.68x | — | -146.99% | — | $0.55 |
AMGNAmgen Inc | 5.20x | 9.95% | 73.30% | 2.93% | $350.16 |
GILDGilead Sciences Inc | 5.71x | 2.40% | 78.83% | 133.64% | $135.87 |
ARGXargenx SE American Depositary Shares | 12.59x | 89.56% | 150.91% | — | $834.45 |
BNTXBioNTech SE American Depositary Share | 9.06x | -11.81% | 84.21% | — | $105.19 |
BIIBBiogen Inc. Common Stock | 2.72x | 2.22% | 75.69% | -18.77% | $183.34 |
MRNAModerna, Inc. Common Stock | 10.91x | -39.93% | 70.32% | — | $54.59 |
NBIXNeurocrine Biosciences Inc | 4.64x | 21.45% | 98.18% | 2.31% | $131.59 |
EXELExelixis Inc | 4.89x | 6.85% | 96.39% | 31.10% | $43.61 |
TECHBio-Techne Corp. | 7.72x | 1.64% | 66.60% | -20.58% | $60.58 |
IBRXImmunityBio, Inc. Common Stock | 74.42x | 668.31% | 99.34% | — | $8.20 |
About
Scinai Immunotherapeutics operates a diversified biopharmaceutical model combining contract manufacturing services with proprietary drug development. The company's CDMO division provides drug development and GMP manufacturing support to biotech clients, representing the majority of current revenue. In-house, it is developing NanoAbs—nanosized VHH antibodies—targeting inflammation and immunology conditions with significant unmet medical needs.